Program
Course
Swinburne - Applied Innovation Studio Mannheim - DTP
Modality
Modality B
Academic year
2022-23
Keywords
Description
The need for advanced solutions in blood cancer patient care is pressing, as current blood testing methods and cancer treatments are invasive and emotionally challenging. The Rapid Blood Analysis (RBA) wearable device caters to this demand by offering a non-invasive and personalized alternative for blood analysis, emergency response, and medication delivery, significantly enhancing patients’ overall experience. RBA exemplifies innovation in blood cancer treatment by leveraging cutting-edge hyperspectral imaging technology. The device’s patient-centered design showcases a commitment to compassionate care, making it a groundbreaking advancement.